Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD22
138 Products
138 Products
740 Diseases
3406 News
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Besponsa
(inotuzumab ozogamicin) / Pfizer
Epratucyn
(epratuzumab) / Gilead
Lumoxiti
(moxetumomab pasudotox) / AstraZeneca
LymphoCide Y-90
(epratuzumab Y-90) / Gilead
4SCAR-T
/ SZGIMI
BL-22
/ AstraZeneca
CTA101
/ Nanjing Bioheng Biotech
LCAR-AIO
/ Legend Biotech
anti-CD19/CD22 CAR-T cells
/ Hrain Biotech
firicabtagene autoleucel
(CRG-022) / CARGO Therap
CART22
/ University of Pennsylvania
CD19/CD22 CAR-T cell therapy
/ Shanghai Yake Biotech
GC022F
/ AstraZeneca
Senl_22
/ SenlangBio
Senl_H19x22P
/ SenlangBio
rezetamig
(JNJ-8780) / J&J
suciraslimab
(SM03) / SinoMab
CD19-CD22 CAR-T
/ Shanghai Ultra-T Immune Therap
CD19/CD22 CAR T-cells
/ National Cancer Institute
HY004
/ Juventas Cell Therapy
AUTO3
/ Autolus
Anti-CD22 CAR-T Cells
/ Beijing Boren Hospital
B019
/ Shanghai Pharma
CART-19/22
/ Shanghai Unicar
CD19 and CD22 targeted prime CAR-T
/ Chongqing Precision Biotech
CD19/CD22 chimeric antigen receptor T cell
/ Kecellitics Biotech
CD19x22 CAR T
/ University of Colorado
CD22/CD19 CAR T
/ The First Affiliated Hospital of Soochow University
CT120
/ IASO BIO
Combotox
(Imtox19/Imtox22) / Montefiore Medical Center, National Cancer Institute, Abiogen
IMJ995
/ Novartis
KQ-2002
/ Novatim Immune Therap
LB1909
/ Legend Biotech
OXS-1550
/ GT Biopharma
ThisCART22
/ Fundamenta Therap
TriCAR19.20.22 T cells
/ The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Instit
anti-CD22 CAR T
/ National Cancer Institute
lasmecabtagene timgedleucel
(UCART22) / Cellectis
multi-target gene-modified CAR-T/TCR-T cell immunotherapy
/ Shenzhen BinDeBio
pinatuzumab vedotin
(RG7593) / Roche
sequential different B cell antigen-targeted CAR T-cell therapy
/ Beijing Boren Hospital
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
/ SZGIMI
AUTO1/22
/ Autolus
Anti-CD22 CAR NK Cells
/ Allife Medicine
CAR-T CD19/CD20/CD22/CD30
/ Shanghai Unicar
CAR-T19/CAR-T22 immunotherapy
/ Shenzhen BinDeBio
CAR20.19.22 T
/ Medical College of Wisconsin, Miltenyi Biomedicine
CART22
/ Academy of Military Medical Sciences
CART2219.1
/ KK Women's and Children's Hospital
CD19/CD20/CD22 CAR-T
/ Xuzhou Medical University
1
2
»